Stem Cell Assay Market Worth 1978.7 Million USD by 2023PR Newswire (press release)Based on region, the Stem Cell Assay Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America dominated the market in … Continue reading
Targeted OncologyTrials Consider Role of Immunotherapy in Breast CancerTargeted Oncology“The tumor types where we have seen the most robust responses to immunotherapies used on their own—melanoma and lung cancer—have genetic mutations that occurred dur… Continue reading
|
Disease Models from Human Pluripotent Stem Cells Now Commercially Available
PR Newswire (press release) Elixirgen Scientific’s proprietary technology (Quick-Tissue™) makes highly efficient differentiation of hPSCs, such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), possible in under 10 days, the fastest speed in the world … |
|
Disease Models from Human Pluripotent Stem Cells Now Commercially Available
PR Newswire (press release) Elixirgen Scientific’s proprietary technology (Quick-Tissue™) makes highly efficient differentiation of hPSCs, such as induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), possible in under 10 days, the fastest speed in the world … |
|
Synthego Appoints CRISPR Pioneer Dr. Jennifer Doudna to Advisory Board to Accelerate Company’s Genome …
PR Newswire (press release) Discovered by Doudna and her team in 2012, CRISPR now serves as the foundation for modern genome engineering and is considered one of the most exciting life sciences advancements in history. Using CRISPR, scientists can precisely and efficiently edit … |